Insurance Coverage Policies for Pharmacogenomic and Multi-Gene Testing for Cancer. (Q55458851)

12 July 2018

title

Insurance Coverage Policies for Pharmacogenomic and Multi-Gene Testing for Cancer. (English)

1 reference

12 July 2018

1 reference

Ellen Wright Clayton

6

0 references

Kathleen M Mazor

4

object named as

Kathleen M Mazor

1 reference

12 July 2018

author name string

Christine Y Lu

1

1 reference

12 July 2018

Stephanie Loomer

2

1 reference

12 July 2018

Rachel Ceccarelli

3

1 reference

12 July 2018

James Sabin

5

1 reference

12 July 2018

Geoffrey S Ginsburg

7

1 reference

12 July 2018

Ann Chen Wu

8

1 reference

12 July 2018

publication date

16 May 2018

1 reference

12 July 2018

Journal of personalized medicine

published in

1 reference

12 July 2018

volume

8

1 reference

12 July 2018

issue

2

1 reference

12 July 2018

Creative Commons Attribution 4.0 International

copyright license

start time

16 May 2018

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Payer coverage policies for multigene tests

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6023380

Non-Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6023380

Payer decision making for next-generation sequencing-based genetic tests: insights from cell-free DNA prenatal screening.

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6023380

Challenges of coverage policy development for next-generation tumor sequencing panels: experts and payers weigh in.

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6023380

Broad, Hybrid Capture-Based Next-Generation Sequencing Identifies Actionable Genomic Alterations in Lung Adenocarcinomas Otherwise Negative for Such Alterations by Other Genomic Testing Approaches

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6023380

Insurance coverage policies for personalized medicine

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6023380

Cancer of unknown primary site.

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6023380

Clinical tumor sequencing: an incidental casualty of the American College of Medical Genetics and Genomics recommendations for reporting of incidental findings.

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6023380

Epidermal growth factor receptor tyrosine kinase (EGFR-TK) mutation testing in adults with locally advanced or metastatic non-small cell lung cancer: a systematic review and cost-effectiveness analysis

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6023380

Clinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk assessment

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6023380

Panel-based testing for inherited colorectal cancer: a descriptive study of clinical testing performed by a US laboratory.

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6023380

Cancer genomics and inherited risk

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6023380

Prioritizing genomic applications for action by level of evidence: a horizon-scanning method

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6023380

ACMG clinical laboratory standards for next-generation sequencing

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6023380

ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6023380

Designs and challenges for personalized medicine studies in oncology: focus on the SHIVA trial.

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6023380

The introduction of systematic genomic testing for patients with non-small-cell lung cancer

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6023380

Personalized medicine in a phase I clinical trials program: the MD Anderson Cancer Center initiative

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6023380

Molecular profiling of patients with colorectal cancer and matched targeted therapy in phase I clinical trials.

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6023380

Clinical and economic challenges facing pharmacogenomics

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6023380

Genetic testing and cancer risk management recommendations by physicians for at-risk relatives

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6023380

Personalized medicine: factors influencing reimbursement.

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6023380

Closing the evidence gap in the use of emerging testing technologies in clinical practice

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6023380

Racial and ethnic disparities in the receipt of cancer treatment

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6023380

Access to Guideline-Recommended Pharmacogenomic Tests for Cancer Treatments: Experience of Providers and Patients.

15 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6023380

American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility.

12 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6023380

Economic incentives for evidence generation: promoting an efficient path to personalized medicine.

12 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6023380

Pilot study using molecular profiling of patients' tumors to find potential targets and select treatments for their refractory cancers.

12 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=6023380

New era of personalized medicine: a 10-year anniversary

12 August 2018

1 reference

12 December 2020

Can genomics bend the cost curve?

1 reference

12 December 2020

Special report: multiple molecular testing of cancers to identify targeted therapies

1 reference

12 December 2020

Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel

1 reference

12 December 2020

Genetic testing insurance coverage trends: a review of publicly available policies from the largest US payers

1 reference

12 December 2020

Identifiers

DOI

10.3390/JPM8020019

1 reference

12 July 2018

PMCID

6023380

1 reference

12 July 2018

PubMed ID

29772692

1 reference

12 July 2018